Treatment of persistent COVID-19 in two B-cell-depleted patients with the monoclonal antibody Sotrovimab
Abstract: Background: Patients having undergone B-cell-depletion with anti-CD20-antibodies have a higher risk of mortality, delayed viral clearance and prolonged infection due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We…